Worldwide Clinical Trials
Mike Mencer, PMP has over 20 years of experience in the pharmaceutical and biotech industry. Mike is currently serving as the Executive Vice President and General Manager for Early Phase Clinical Services at Worldwide Clinical Trials since January 2020. Prior to this role, they worked as a Principal at DMM Triangle Services, LLC where they provided consulting services to the pharmaceutical, biotech, and CRO industry starting from October 2017.
From May 2018 to October 2019, Mike worked as the Executive Director of Business Development Operations at Acurian Inc. Before that, they held various leadership positions at Patheon, including Vice President of Pharmaceutical Development Services, Senior Director of Global Integrated Offering, and Senior Director of Pharmaceutical Development Services UK & France.
Additionally, Mike has worked as an Adjunct Professor at the University of Cincinnati's Division of Pharmaceutical Sciences from September 2011 to June 2013. Mike began their career at Teva Pharmaceuticals as a Supervisor before joining Patheon.
Mike Mencer, PMP has a strong background in project management and extensive experience in the pharmaceutical and biotech industry, making him a valuable asset in their current role at Worldwide Clinical Trials.
Mike Mencer, PMP holds a Bachelor's degree in Chemistry from Xavier University. Mike has also completed the Leadership Development Program at the Center for Creative Leadership. Additionally, they possess the Project Management Professional certification awarded by the Project Management Institute in 2004.
Worldwide Clinical Trials
11 followers
About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.